Welch, Nicole L. http://orcid.org/0000-0002-1163-7002
Zhu, Meilin http://orcid.org/0000-0003-1302-4020
Hua, Catherine http://orcid.org/0000-0003-0455-5364
Weller, Juliane
Mirhashemi, Marzieh Ezzaty
Nguyen, Tien G.
Mantena, Sreekar http://orcid.org/0000-0002-8834-1461
Bauer, Matthew R.
Shaw, Bennett M.
Ackerman, Cheri M.
Thakku, Sri Gowtham
Tse, Megan W. http://orcid.org/0000-0002-4968-7072
Kehe, Jared
Uwera, Marie-Martine
Eversley, Jacqueline S.
Bielwaski, Derek A.
McGrath, Graham
Braidt, Joseph
Johnson, Jeremy
Cerrato, Felecia
Moreno, Gage K.
Krasilnikova, Lydia A. http://orcid.org/0000-0003-4163-706X
Petros, Brittany A. http://orcid.org/0000-0003-2110-7475
Gionet, Gabrielle L.
King, Ewa
Huard, Richard C.
Jalbert, Samantha K.
Cleary, Michael L.
Fitzgerald, Nicholas A.
Gabriel, Stacey B.
Gallagher, Glen R. http://orcid.org/0000-0001-6837-9473
Smole, Sandra C.
Madoff, Lawrence C. http://orcid.org/0000-0003-2589-7777
Brown, Catherine M.
Keller, Matthew W. http://orcid.org/0000-0002-5850-1698
Wilson, Malania M.
Kirby, Marie K. http://orcid.org/0000-0003-0859-9604
Barnes, John R.
Park, Daniel J. http://orcid.org/0000-0001-7226-7781
Siddle, Katherine J.
Happi, Christian T.
Hung, Deborah T.
Springer, Michael
MacInnis, Bronwyn L.
Lemieux, Jacob E.
Rosenberg, Eric
Branda, John A.
Blainey, Paul C. http://orcid.org/0000-0002-4889-8783
Sabeti, Pardis C. http://orcid.org/0000-0002-9843-1890
Myhrvold, Cameron http://orcid.org/0000-0002-8971-184X
Article History
Received: 22 November 2021
Accepted: 3 February 2022
First Online: 7 February 2022
Change Date: 9 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41591-023-02684-y
Competing interests
: N.L.W., S.G.T., C.M.A., D.T.H., P.C.B., P.C.S. and C.M. are coinventors on a patent related to this work. P.C.B is a coinventor on patent applications concerning droplet array technologies and serves as a consultant and equity holder of companies in the microfluidics and life sciences industries, including 10x Genomics, GALT, Celsius Therapeutics, Next Gen Diagnostics, Cache DNA and Concerto Biosciences. P.C.B.’s laboratory receives funding from industry for unrelated work. J.E.L. has received consulting fees from Sherlock Biosciences. J.A.B. has received research support for other studies from Pfizer, Zeus, bioMérieux, Immunetics, Abbott Rapid Diagnostics (formerly Alere), Diasorin and the Bay Area Lyme Foundation. P.C.S. is a cofounder of and consultant to Sherlock Biosciences and a board member of the Danaher Corporation, and holds equity in the companies. The other authors declare no competing interests.